tiprankstipranks
Trending News
More News >
Emami Limited (IN:EMAMILTD)
:EMAMILTD
India Market

Emami Limited (EMAMILTD) AI Stock Analysis

Compare
0 Followers

Top Page

IN:EMAMILTD

Emami Limited

(EMAMILTD)

Select Model
Select Model
Select Model
Neutral 64 (OpenAI - 5.2)
,
Neutral 64 (OpenAI - 5.2)
,
Neutral 64 (OpenAI - 5.2)
Rating:64Neutral
Price Target:
₹445.00
▼(-15.42% Downside)
Action:ReiteratedDate:11/08/25
Emami Limited's overall stock score is primarily driven by its strong financial performance, characterized by robust revenue growth and profitability margins. However, the technical analysis indicates bearish momentum, which negatively impacts the score. The valuation is reasonable but not particularly attractive. The absence of earnings call data and corporate events means these factors do not influence the score.
Positive Factors
Very strong balance sheet and low leverage
An equity ratio of 76.26%, debt-to-equity of 0.03 and ROE near 29.9% indicate durable financial resilience. Low leverage reduces refinancing and interest-rate risk, preserving capacity to fund brand marketing, distribution and working capital needs without sacrificing financial flexibility over the medium term.
Robust free cash flow generation
FCF growth of 15.28% and OCF exceeding reported net income (OCF/Net = 1.11) show strong cash conversion. This durable cash generation supports repeatable reinvestment in brands, capex and inventory while enabling shareholder returns or debt reduction without relying on external financing.
High and sustainable profitability margins
Very high gross and operating margins indicate durable pricing power and efficient cost structure. Sustained margins (EBIT 38.7%, EBITDA 26.5%) provide scope to fund marketing, new SKUs and distribution, helping maintain market position and protect profitability through medium-term industry cycles.
Negative Factors
Increase in total liabilities to monitor
Although overall leverage is low, rising total liabilities could reflect growing trade payables, provisions or contingent items that may strain working capital or compress margins if persistent. Continued increases would erode liquidity buffers and reduce flexibility for brand investments.
Historical net income volatility
A past decline in net income signals earnings sensitivity to demand, input costs or one-off items. Even with strong recent margins, this volatility reduces predictability and raises the risk that margins and ROE could revert under negative shocks, complicating medium-term forecasting.
Limited earnings-call data and event disclosure
Absence of earnings-call details and guidance reduces transparency about management’s near-term strategy and outlook. Over 2–6 months this limits investors' ability to assess forward plans for pricing, new products or distribution, increasing forecasting risk and governance scrutiny.

Emami Limited (EMAMILTD) vs. iShares MSCI India ETF (INDA)

Emami Limited Business Overview & Revenue Model

Company DescriptionEmami Limited manufactures and markets personal and healthcare products in India and internationally. It provides ayurvedic antiseptic cream, prickly heat powder, doodh kesar body lotion, vasocare herbal petroleum jelly, aloe vera gel, and hygiene products under the Boroplus brand; cool oil, extra thanda, gold ayurvedic oil, therapy ayurvedic body massage and stress relief oil, maxx cool talc, and cool talc under the Navratna brand; balm, balm ultra-power, quick relief roll-on, ortho vedic oil, healthcare products, pancharishta, nityam, kesari jivan, and ayurvedic hand sanitizers under the Zandu brand; radiance cream and instant radiance face wash for men under the Fair and Handsome brand; haircare products under the Kesh King brand; pain reliever balm under the Mentho Plus brand; and pain relief ointment under the Fast Relief brand. The company also offers prickly heat powder under the Dermicool brand; non sticky hair oil under the Emami 7 Oils in One brand; deodorants under the HE brand; hair colors under the Diamond Shine brand; talc under the Emami Golden Beauty brand; herbal fairness cream under the Emami Naturally Fair brand; home hygiene solutions under the Emasol brand; and normal, dry, and ultra-dry skin products under the Cream21 brand. Emami Limited was founded in 1974 and is headquartered in Kolkata, India.
How the Company Makes MoneyEmami Limited makes money primarily by manufacturing (directly and/or via third-party/contract manufacturers) and selling branded FMCG products to a network of trade channels (e.g., distributors/stockists, wholesalers, and modern retail), as well as to institutional or other bulk buyers where applicable. Revenue is largely generated from product sales across its core categories—personal care, healthcare/OTC-style products, and beauty—where the company earns a margin between its net realization (after trade schemes/discounts and returns) and its cost to produce, procure, package, and distribute products, along with brand-building and selling expenses. Key earnings drivers typically include (i) volume growth and product mix (higher-margin brands and premium SKUs), (ii) pricing actions and input-cost management that affect gross margins, (iii) distribution reach and marketing effectiveness that support brand demand, and (iv) working-capital efficiency and supply-chain execution that influence profitability. Specific details on the exact category-wise revenue split, major named partnerships, or contract-manufacturing arrangements are null.

Emami Limited Financial Statement Overview

Summary
Emami Limited demonstrates impressive financial health with robust revenue growth, strong profitability margins, and effective debt management. The company's consistent performance in generating free cash flow and maintaining a high equity ratio underlines its financial stability and operational efficiency. While slight concerns exist regarding fluctuating net income and increasing liabilities, the overall trajectory remains positive, reflecting a well-managed business poised for continued success.
Income Statement
85
Very Positive
Emami Limited has shown a consistent increase in revenue over the years, with a notable revenue growth rate of 6.45% from 2024 to 2025. The company maintains a strong gross profit margin of 68.64% and a net profit margin of 21.17% in 2025, indicating efficient cost management and profitability. The EBIT and EBITDA margins of 38.70% and 26.52% respectively, further highlight the company's strong operational performance. However, the decline in net income from 2022 to 2023 poses a slight concern for sustained profitability.
Balance Sheet
78
Positive
The balance sheet reflects a solid equity base with an equity ratio of 76.26% in 2025, emphasizing financial stability. The debt-to-equity ratio is low at 0.03, showcasing prudent debt management. Return on equity (ROE) is strong at 29.92%, indicating effective use of shareholder funds to generate profit. A notable strength is the reduction in total debt over the years, though the increase in total liabilities from 2024 to 2025 may warrant monitoring.
Cash Flow
82
Very Positive
The cash flow statement highlights a robust free cash flow growth rate of 15.28% from 2024 to 2025, driven by increased operating cash flow. The operating cash flow to net income ratio of 1.11 indicates healthy cash generation relative to reported profits. The free cash flow to net income ratio of 1.06 suggests strong cash conversion, although the consistent negative investing and financing cash flows could imply ongoing capital investments and debt repayments.
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue37.15B38.09B35.78B34.06B31.87B28.81B
Gross Profit25.67B26.15B23.78B22.04B20.58B19.34B
EBITDA9.98B10.10B9.90B9.14B10.41B9.53B
Net Income7.54B8.06B7.24B6.40B8.39B4.55B
Balance Sheet
Total Assets36.71B35.34B32.80B31.10B30.57B25.20B
Cash, Cash Equivalents and Short-Term Investments8.90B8.26B4.09B2.99B1.83B4.46B
Total Debt719.60M897.80M939.56M905.10M2.82B1.01B
Total Liabilities7.42B8.40B8.22B7.97B9.83B7.58B
Stockholders Equity29.31B26.95B24.47B23.03B20.77B17.63B
Cash Flow
Free Cash Flow2.15B8.51B7.38B7.08B1.60B8.88B
Operating Cash Flow2.35B8.96B7.79B7.49B6.44B9.22B
Investing Cash Flow-892.30M-3.40B-2.05B-1.13B-2.35B-2.27B
Financing Cash Flow-1.80B-5.00B-5.63B-6.08B-4.02B-6.88B

Emami Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price526.15
Price Trends
50DMA
485.19
Negative
100DMA
502.83
Negative
200DMA
535.24
Negative
Market Momentum
MACD
-16.60
Positive
RSI
21.67
Positive
STOCH
3.41
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:EMAMILTD, the sentiment is Negative. The current price of 526.15 is above the 20-day moving average (MA) of 465.54, above the 50-day MA of 485.19, and below the 200-day MA of 535.24, indicating a bearish trend. The MACD of -16.60 indicates Positive momentum. The RSI at 21.67 is Positive, neither overbought nor oversold. The STOCH value of 3.41 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:EMAMILTD.

Emami Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
₹184.13B20.066.86%6.83%8.79%
68
Neutral
₹131.48B42.680.26%5.73%-7.74%
66
Neutral
₹128.49B-90.620.28%14.55%-20.61%
64
Neutral
₹182.59B18.061.91%0.84%-2.44%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
61
Neutral
₹80.60B31.991.24%1.62%-7.32%
57
Neutral
₹158.63B41.301.16%0.73%-5.88%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:EMAMILTD
Emami Limited
415.85
-117.60
-22.04%
IN:CASTROLIND
Castrol India Limited
186.15
-36.73
-16.48%
IN:CROMPTON
Crompton Greaves Consumer Electricals Ltd.
246.35
-103.34
-29.55%
IN:FINEORG
Fine Organic Industries Ltd.
4,288.45
568.43
15.28%
IN:JYOTHYLAB
Jyothy Labs Limited
219.50
-108.41
-33.06%
IN:ZYDUSWELL
Zydus Wellness Limited
403.85
83.32
25.99%

Emami Limited Corporate Events

Emami Withdraws From IIFL Global Investors’ Conference Citing Exigencies
Feb 19, 2026

Emami Limited has notified the stock exchanges that it will not participate in the IIFL 17th Enterprising India Global Investors’ Conference scheduled to be held physically in Mumbai on 25 February 2026. The company cited certain exigencies as the reason for cancelling its planned attendance, temporarily reducing an opportunity for direct engagement with analysts and institutional investors.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 08, 2025